The largest database of trusted experimental protocols

71 protocols using annexin 5

1

Annexin V and PI Staining

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were plated in a 6 cm culture dish at a seeding density of 5 × 106 cells/dish. Following statin treatment, the medium was removed and washed twice with PBS. The cells were trypsinized, collected by centrifugation, resuspended in 500 μL of 1X Annexin V Binding Buffer mixed with 1 μL of Annexin V (BioVision) and 1 μL of Propidium Iodide (BioVision), and incubated at room temperature for 15 min in darkness. The reaction volume was adjusted with the binding buffer to 1 mL. The cells were analyzed using a flow cytometer (Cytomics FC 500) with a single laser emitting excitation light at 488 nm.
+ Open protocol
+ Expand
2

Apoptosis and Growth Inhibition Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The percentage of apoptotic cells was measured by flow cytometry after staining with a combination of Annexin V (Abcam, Cambridge, MA) and propidium iodide10 (link). Growth-inhibitory effects were assessed using a Cell Counting Kit (Dojindo, Kumamoto, Japan). A combination index, used to assess synergistic effects, was calculated using CompuSyn software11 (link).
+ Open protocol
+ Expand
3

Osteocyte Apoptosis and RANKL Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fixed left femurs were decalcified in 14% EDTA (~2 weeks) and embedded in paraffin. Serial longitudinal 5 μm sections were taken and stained using an avidin–biotin method. Samples were stained for receptor activator of nuclear factor κB ligand (RANKL; Abcam, Cambridge, MA, USA) and annexin V (Abcam), an early marker of cellular apoptosis. Counterstaining and negative controls for all antibodies were conducted using methods as previously described (Metzger et al., 2021a ; Metzger et al., 2020a (link)). Sections were analyzed in a standard ROI in the cortical bone of the femur midshaft. Results were reported as the percentage of osteocytes stained positively for the protein out of all osteocytes within the ROI. All analyses were completed by the same blinded investigator.
+ Open protocol
+ Expand
4

Humeral Osteocyte Immunostaining Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fixed right humeri were decalcified in 14% EDTA (~14 days) and embedded in paraffin. Serial 5 μm sections were taken. Sections were stained utilizing a standard avidin-biotin method as previously described [9 (link)]. Samples were stained for receptor activator of nuclear factor κB ligand (RANKL; Abcam, Cambridge, MA, USA), annexin V (Abcam), an early marker of cellular apoptosis, and two proinflammatory cytokines, tumor necrosis factor-α (TNF-α; Abcam) and interleukin-17 (IL-17; Abcam). Peroxidase development was performed with an enzyme substrate kit (DAB, Vector Laboratories, Burlingame, CA, USA). Counterstaining was conducted with methyl green (Vector Laboratories) which stain osteocyte nuclei. Negative controls for all antibodies were completed by omitting the primary antibody. Sections of the entire humeral midshaft cortical bone in cross-section were analyzed and results are reported as the percentage of osteocytes stained positively for the protein (DAB-positive) relative to all osteocytes (DAB-positive and methyl green-positive) in the cross-section. All analyses were completed by the same individual.
+ Open protocol
+ Expand
5

Apoptosis Analysis by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Apoptosis was analyzed by flow cytometry using the double staining with lipophilic Annexin V and 7-amino actinomycin D (7-AAD) (Abcam, Cambridge, United Kingdom), as described elsewhere (Wang et al., 2017 (link)). Briefly, after treatment, cells were harvested and washed with FACS buffer. Thereafter, cells were resuspended in 100 μl binding buffer (eBioscience) with 2.5 μl Annexin V (eBioscience) and incubated for 20 min at room temperature. 7-AAD (5 μl) was added 5 min before analysis. Early apoptotic cells (Annexin V-positive, 7-AAD-negative), necrotic/late apoptotic cells (double-positive), and living cells (double-negative) were determined by flow cytometry (BD LSR Fortsessa, BD Bioscience, Franklin Lakes, NJ, United States).
+ Open protocol
+ Expand
6

Protein Expression Analysis by SDS-PAGE and Western Blotting

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sodium dodecyl sulphate polyacrylamide gel electrophoresis and western blotting were performed as described previously.57 (link), 58 (link) The following antibodies were used: p16 (Santa Cruz Biotechnology, Dallas, TX, USA, #sc-56330), MDR1/P-gp (Santa Cruz Biotechnology, #sc-1517), calnexin (Santa Cruz Biotechnology, #sc-80645), α-tubulin (Santa Cruz Biotechnology, #sc-32293), annexin V (Abcam, #ab14196), CD63 and HSP70 (System Biosciences, Palo Alto, CA, USA, #EXOAB-CD63A-1), p21 (BD Biosciences, #556430), GAPDH (Cell Signalling, #5174P) and Na/K ATPase (Novus Biologicals, Littleton, CO, USA #NB300-146). The differential CD63 bands potentially represents either differential glycosylation59 (link) or the isolation method used to harvest EVs.60 (link) Densitometry was completed to determine the expression of proteins. Densitometry was completed using Image J software with all results normalised to the loading control.
+ Open protocol
+ Expand
7

Multiparameter Flow Cytometry and Immunoblotting

Check if the same lab product or an alternative is used in the 5 most similar protocols
Monoclonal antibodies (Abs) specific for cluster of differentiation (CD)1a, CD14, CD38, CD86, CD83, HLA-DR, IgG1, IgG2a (BD Bioscience, San Diego, CA, USA), and Annexin V (Abcam, Cambridge, UK) were used as direct conjugates to Fluorescein Isothiocyanate (FITC), Phycoerythrin (PE) as needed. To exclude dead cells from analysis Fixable Viability Dye eFluor®780 (FvDye, eBioscience, San Diego, CA, USA) was used. For immunoblotting analysis rabbit anti-phospho-NF-kB p65 (Ser536), rabbit anti-phospho-p44/42 MAPK (Thr202/Tyr204), rabbit anti-phospho-p38 MAPK (Thr180/Tyr182) (Cell Signaling Technology, Danvers, MA), mouse anti-β-actin (Sigma-Aldrich, St. Louis, MO, USA) and horseradish peroxidase-conjugate anti-mouse (Santa Cruz Biotechnology, Dallas, TX, USA) and anti-rabbit (Santa Cruz Biotechnology) secondary Abs were used. Staurosporine (1 μM, Sigma Aldrich) was utilized as pharmacological inducer of apoptosis.
+ Open protocol
+ Expand
8

Efferocytosis Assay of Apoptotic Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
GFP expressing LR73 fibroblasts were seeded in a 24-well plate at a density of 0.2×105 cells per well. Next day, cells were treated with Lipofectamine 2000 (Thermo Fisher) with specific siRNAs according to the manufacturer’s protocol, two days prior to efferocytosis assays. Thymocytes were isolated from 4 to 6-week-old mice and treated with 25 μM dexamethasone for 4 h to induce apoptosis. Apoptotic thymocytes were then stained with 10 μM TAMRA in serum-free HBSS for 45 min at 37 °C, washed, and incubated in serum-containing assay media for an additional 25min. Phagocytes were pre-incubated with Cytochalasin D (Sigma-Aldrich, 1 μM) for 1 h and, in some experiments, Tritbutyltin chloride (Sigma; 10 μM for 6 h), or with RGDS peptide for 30 min (Tocris 100 μM); in some cases apoptotic cells were incubated with Annexin V (Abcam, 10 μg/ml for 30 min). Apoptotic cells were subsequently co-cultured with phagocytes, in the presence of vehicle or indicated inhibitor, at a 1:10 phagocyte to target ratio for 30 minutes. After the incubation, apoptotic cells were removed via three cold PBS washes and phagocytes were harvested via trypsin/EDTA and assessed for the percentage and MFI of GFP+ TAMRA+ LR73 cells by flow cytometry.
+ Open protocol
+ Expand
9

Immunofluorescence Analysis of PI3K/AKT Pathway in FaDu Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
After treatment with NP-Ø and NP-427, the FaDu seeded in 24-well plates were fixed with 4% paraformaldehyde (PFA) for 10 min. The cells were blocked for 1 h at 37 °C and incubated overnight at 4 °C with several antibodies: p-AKT-Ser473 (1/75), p-AKT-Thr308 (1/75), and Annexin-V (1/100) from Abcam (Abcam, Cambridge, UK) and p-PDK1-Ser241 and anti-PI3CA (1/100) from Invitrogen (Invitrogen Corporation y Applied Biosystems Inc., Carlsbad, United States). After, the cells were incubated with the secondary antibodies, i.e., Alexa Fluor 546-conjugated goat anti-rabbit antibody (1/250; Molecular Probes, Eugene, United States) or Alexa Fluor 488-conjugated goat anti-rabbit antibody (1/250; Molecular Probes, Eugene, United States). at 37 °C for 45 min. Then, the cells were stained with 300 nM of 4′,6-diamidino-2-phenylindole dihydrochloride (DAPI; Sigma-Aldrich, San Luis, CA, United States), reactive with fluorescent blue, which intercalates with DNA, for 5 min at 37 °C. Fluorescence was visualized using an Olympus BX51 microscope. The specificity was assessed by omitting the primary antibody. ImageJ, a free image-processing program, was used for quantitative analysis of the image.
+ Open protocol
+ Expand
10

Annexin V-FITC/7-AAD Apoptosis Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Apoptosis was analyzed by using the double staining with the lipophilic dye Annexin V and 7-amino actinomycin D (7-AAD) (Abcam, Cambridge, UK). Briefly, 0.5 × 106 cells were treated with AF for 2 h, harvested by trypsin, washed twice with PBS and resuspended in 100 μl. Thereafter, 2.5 μl Annexin V-FITC and 5 μl 7-AAD were added to the cell suspensions and incubated for 20 min at room temperature in the dark. Early apoptotic cells (Annexin V-positive, 7-AAD-negative), necrotic/late apoptotic cells (double-positive), and living cells (double-negative) were determined by flow cytometry (BD LSR Fortsessa, BD Bioscience, Franklin Lakes, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!